Skip to main content
Fig. 5 | BMC Genomics

Fig. 5

From: Features of alternative splicing in stomach adenocarcinoma and their clinical implication: a research based on massive sequencing data

Fig. 5

Construction of prognostic signatures based on LASSO COX analysis. Each right subfigure shows the Log Lambda value corresponding to the minimum cross-validation error point. And the AS events with non-zero coefficient corresponding to the same Log Lambda value were selected in the left figure for subsequent model construction. a Alternate Acceptor site (AA); b Alternate Donor site (AD); c Alternate Promoter (AP); d Alternate Terminator (AT); e Exon Skip (ES); f Mutually Exclusive Exons (ME); g Retained Intron (RI); and h All types of AS

Back to article page